Which diagnostic imaging studies should be ordered to evaluate a suspicious lymph node?

Diagnostic Imaging for Suspicious Lymph Node Evaluation

For a suspicious lymph node, order contrast-enhanced CT of the neck (or MRI with contrast if CT is contraindicated) as the primary imaging modality, with ultrasound-guided fine-needle aspiration (FNA) performed in parallel for tissue diagnosis. 1

Initial Imaging Strategy

The choice of imaging depends critically on the clinical context and suspected primary malignancy:

For Suspected Head and Neck Malignancy

• Contrast-enhanced CT neck is the gold standard for patients at increased risk for malignancy (age >40, smoking history, or any adult with persistent lymphadenopathy) 1
• CT provides rapid assessment, excellent anatomic detail, and screens the upper aerodigestive tract for occult primary tumors
• MRI with contrast is an equally effective alternative, particularly useful for:
  • Patients with contrast allergy or renal insufficiency (with protocol modifications)
  • Claustrophobic patients who cannot tolerate MRI may prefer CT
  • Radiation exposure concerns 1

For Suspected Lymphoma

PET-CT is the preferred imaging modality for FDG-avid lymphomas (essentially all histologies except CLL/SLL, lymphoplasmacytic lymphoma, mycosis fungoides, and marginal zone lymphomas) 2

• PET-CT should extend from skull base to mid-thigh for comprehensive staging
• Contrast-enhanced CT component is recommended for accurate nodal size measurement and to distinguish bowel from lymphadenopathy 2
• For non-FDG-avid lymphomas, contrast-enhanced CT alone is preferred 2
• PET-CT changes stage in 10-30% of patients and is critical for baseline assessment before therapy 2

For Suspected Thyroid Cancer Metastasis

Neck ultrasound is the key initial test 3, 4

• Ultrasound can detect lymph nodes as small as 2-3 mm
• Suspicious sonographic features include: irregular shape, loss of fatty hilum, increased cortical thickness >3.5 mm, cystic areas, microcalcifications, or abnormal vascularity 3, 4
• If lymph node is sonographically suspicious, perform ultrasound-guided FNA with thyroglobulin measurement in the washout fluid 3, 4
  • Thyroglobulin >100 ng/mL in washout fluid is typical for metastatic lymphadenopathy
  • For medullary thyroid cancer, measure calcitonin in washout fluid (>23 pg/mL has 100% sensitivity/specificity) 4

For Suspected Lung Cancer

PET-CT from skull base to mid-thigh is recommended for staging in most non-small cell lung cancer patients 5

• In patients with discrete mediastinal lymph node enlargement (with or without PET uptake), invasive staging with EBUS-NA, EUS-NA, or combined EBUS/EUS-NA is recommended over imaging alone 5
• Tissue sampling of suspicious distant metastases is imperative before excluding patients from curative treatment 5

Ultrasound as a Complementary Tool

Ultrasound plays a critical adjunctive role across multiple scenarios:

• Highest accuracy when combined with FNA - provides 98.2% accuracy for supraclavicular nodes and 93.2% for internal mammary nodes in breast cancer 6
• Ultrasound elastography shows superior diagnostic performance at the patient level for axillary lymph node assessment (superiority index 5.95, AUC 0.92) 7
• Adding elastography to B-mode and Doppler ultrasound increases diagnostic sensitivity to 90.4% and accuracy to 73.9% 8

Critical Pitfalls to Avoid

1. Do not rely on imaging characteristics alone - tissue diagnosis is essential for suspected malignancy 1
2. Do not skip FNA of suspicious internal mammary nodes - only 43.2% are directly sampled despite 98.8% PPV when biopsied 6
3. Do not order PET-CT for non-FDG-avid lymphomas - use contrast-enhanced CT instead 2
4. Do not delay imaging in high-risk patients - obtain imaging in parallel with FNA, not sequentially 1
5. For lung cancer staging, do not accept imaging alone for discrete mediastinal adenopathy - invasive staging is required 5

When to Use Advanced Imaging

• MRI: Superior to CT for hilar lymph nodes in lung cancer 9; equivalent to ultrasound for axillary nodes in ER/PR+HER2- breast cancer 10
• PET-CT: Essential for lymphoma staging 2; useful for detecting recurrent lung cancer (90% sensitivity/specificity) 11
• Contrast-enhanced studies: Always preferred when evaluating for malignancy unless contraindicated 1